R. Delva

5.8k citations
84 papers · 4.4k · 2 hit papers · h-index 30

Impact in

    • Prostate Cancer Treatment and Research
    • Prostate Cancer Diagnosis and Treatment
    • Renal cell carcinoma treatment
  • Oncology top 2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology

Papers in

R. Delva

82 papers receiving 4.2k citations

R. Delva's Hit Papers

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial 2015 · 375 citations
3750+4+8Years since publication100200300400500

Peers

R. Delva
Comparison fields: 5 of 107
  • Pulmonary and Respiratory Medicine 2.0k
  • Oncology 1.5k
  • Cancer Research 611
  • Reproductive Medicine 150
  • Hematology 194
Replace Jan B. Vermorken with:
Jan B. Vermorken Belgium
Jozef Mardiak Slovakia
Giacomo Cartenì Italy
Enrique Gallardo Spain
D. Johnston Canada
Tomasz Demkow Poland
PILAR LIANES Spain
Antoine Thiery-Vuillemin France
Michele Aieta Italy
Roberto Petrioli Italy
R. Delva relative to Jan B. Vermorken Belgium Jan B. Vermorken's profile →
Citations per field
00.5×1.7×
Jan B. Vermorken · 1×
Citations per year

Countries citing papers authored by R. Delva

Since Specialization
Citations

This map shows the geographic impact of R. Delva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Delva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Delva more than expected).

Fields of papers citing papers by R. Delva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Delva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Delva. The network helps show where R. Delva may publish in the future.

Co-authors

The 25 scholars most cited alongside R. Delva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Delva Line = papers co-authored together R. Delva links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2013571
2
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
Hit paper breakdown →
2015375
3 2004293
4 2008282
5 2011197
6 1996194
7 2015184
8 1999181
9 2007147
10 2014144
11 1998142
12 2022135
13 2014100
14 201690
15 200882
16
Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients.
199776
17 201369
18 200867
19 200662
20 201455

About R. Delva

R. Delva is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Reproductive Medicine, having authored 84 papers that have together received 4.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (17 papers), Renal cell carcinoma treatment (11 papers), Cancer Treatment and Pharmacology (10 papers), Colorectal Cancer Treatments and Studies (10 papers), Testicular diseases and treatments (10 papers), Bladder and Urothelial Cancer Treatments (5 papers), Breast Cancer Treatment Studies (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.0k citations), Oncology (1.5k citations), Cancer Research (611 citations), Reproductive Medicine (150 citations) and Hematology (194 citations). R. Delva has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Erick C. Gamelin, Michèle Boisdron‐Celle, Alain Morel, Véronique Guerin‐Meyer, Norbert Ifrah, Christine Chevreau, Alain H. Lortholary, F Larra, Sylvie Négrier and Gwénaëlle Gravis. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology, The Lancet Oncology and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact